Unbiased Analysis of Today's Healthcare Issues

“An astonishingly naïve approach”

That was Amitabh Chandra’s comment on Hillary Clinton’s plan to reign in drug prices and I don’t disagree. According to the N.Y. Times, her plan: …includes regulating the percentage of revenues pharmaceutical companies must spend on research and development, instituting a cap on the cost of many out-of-pocket drugs for chronic and serious health conditions, and allocating […]

Read the rest of this entry »